English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, June 6, 2017
山东罗欣药业H股于联交所买卖于2017年6月6日起暂停直至于2017年6月16日撤销上市
山東羅欣藥業H股於聯交所買賣於2017年6月6日起暫停直至於2017年6月16日撤銷上市
Shandong Luoxin Pharmaceutical's H Shares Trading is Suspended from 6 June 2017 until its Delisting on 16 June 2017
Wednesday, May 31, 2017
山东罗欣药业获股东批准撤销H股在联交所的上市地位 要约在各方面成为无条件
山東羅欣藥業獲股東批准撤銷H股在聯交所的上市地位 要約在各方面成為無條件
Shandong Luoxin Pharmaceutical's Withdrawal of Listing H Shares on HKEx Approved by Shareholders; Offer becomes Unconditional in All Respects
Tuesday, April 11, 2017
山东罗欣药业获自愿有条件要约
山東羅欣藥業獲自願有條件要約
Shandong Luoxin Pharmaceutical Receives a Voluntary Conditional Offer
Wednesday, May 8, 2013
罗欣药业公布2013年第一季度业绩

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575